Tapentadol for the Treatment of Moderate-to-Severe Acute Pain in Children Under the Age of Two Years

Acute Pain

Efficacy and safety of multiple doses of tapentadol oral solution in the treatment of moderate to severe acute pain in children aged 2 to <18 years - a randomized, double-blind, placebo-controlled trial

J Pain Res.

Beuter C, Volkers G, Radic T, Goldberg J, van den Anker J

doi: 10.2147/JPR.S207010.

Acute Pain

First evaluation of tapentadol oral solution for the treatment of moderate to severe acute pain in children aged 6 to <18

J Pain Res.

Finkel JC, Goldberg J, Rosenburg R, Ariyawansa J, Sun T, Ochs-Ross R, Zannikos P, Zhang L, Etropolski M

doi: 10.2147/JPR.S197348.

Postoperative Pain

Intravenous meloxicam for the treatment of moderate to severe acute pain: a pooled analysis of safety and opioid-reducing effects

Reg Anesth Pain Med.

Viscusi ER, Gan TJ, Bergese S, Singla N, Mack RJ, McCallum SW, Du W, Hobson S

doi: 10.1136/rapm-2018-100184.

Cancer PainNeuropathic Pain

Multiple effectiveness aspects of tapentadol for moderate-severe cancer-pain treatment: an observational prospective study

J Pain Res.

Cascella M, Forte CA, Bimonte S, Esposito G, Romano C, Costanzo R, Morabito A, Cuomo A

doi: 10.2147/JPR.S181079.

Pain Relief

Efficacy and safety of tapentadol prolonged-release for moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo- and oxycodone controlled-release studies

Curr Med Res Opin.

Lange B, von Zabern D, Elling C, Dubois C

doi: 10.1080/

Acute PainPain Management

ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The µ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy

J Pain Res.

Bergese SD, Brzezinski M, Hammer GB, Beard TL, Pan PH, Mace SE, Berkowitz RD, Cochrane K, Wase L, Minkowitz HS, Habib AS

doi: 10.2147/JPR.S217563.

Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain

Pain Ther.

Pergolizzi JV Jr, Taylor R Jr, LeQuang JA, Raffa RB, Bisney J

doi: 10.1007/s40122-018-0095-8.

RECOMMENDED

Acute PainPostoperative Pain

Risk factors for severe acute pain and persistent pain after surgery for breast cancer: a prospective observational study

Reg Anesth Pain Med.

Habib AS, Kertai MD, Cooter M, Greenup RA, Hwang S

doi: 10.1136/rapm-2018-000040.

COMMENTED

Acute PainPain Management

Safety Issues of Pharmacological Acute Pain Treatment in Children

Clin Pharmacol Ther.

Rodieux F, Piguet V, Desmeules J, Samer CF

doi: 10.1002/cpt.1358.

Related content

Efficacy and safety of multiple doses of tapentadol oral solution in the treatment of moderate to severe acute pain in children aged 2 to <18 years - a randomized, double-blind, placebo-controlled trial

First evaluation of tapentadol oral solution for the treatment of moderate to severe acute pain in children aged 6 to <18

Intravenous meloxicam for the treatment of moderate to severe acute pain: a pooled analysis of safety and opioid-reducing effects

Multiple effectiveness aspects of tapentadol for moderate-severe cancer-pain treatment: an observational prospective study

Efficacy and safety of tapentadol prolonged-release for moderate-to-severe chronic osteoarthritis knee pain: a pooled analysis of two double-blind, randomized, placebo- and oxycodone controlled-release studies

ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The µ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy

Tapentadol Extended Release in the Treatment of Severe Chronic Low Back Pain and Osteoarthritis Pain

Risk factors for severe acute pain and persistent pain after surgery for breast cancer: a prospective observational study

Safety Issues of Pharmacological Acute Pain Treatment in Children